Quick Answer
Avalo Therapeutics, Inc. reported Common Stock Shares Outstanding of 18.51 million shares for the year ending 2025.
- Avalo Therapeutics, Inc. showed an increase of +76.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Avalo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Avalo Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 2,749.3%.
- Historical annual values: Fiscal year 2025: 18.51 million shares | Fiscal year 2024: 10.47 million shares | Fiscal year 2023: 801,746 shares | Fiscal year 2022: 39,294 shares | Fiscal year 2021: 9.40 million shares | Fiscal year 2020: 75.00 million shares | Fiscal year 2019: 44.38 million shares | Fiscal year 2018: 40.80 million shares | Fiscal year 2017: 31.27 million shares | Fiscal year 2016: 9.43 million shares | Fiscal year 2015: 8.65 million shares | Fiscal year 2014: 649,721 shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: